Eisai
4523.T
#2309
Rank
ยฃ6.32 B
Marketcap
ยฃ22.40
Share price
0.48%
Change (1 day)
-5.89%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): ยฃ0.67

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ0.64. In 2026 the company made an earnings per share (EPS) of ยฃ0.63 a decrease over its 2025 EPS that were of ยฃ0.80.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026ยฃ0.63-21.04%
2025ยฃ0.8011.85%
2024ยฃ0.72-32.63%
2023ยฃ1.065.52%
2022ยฃ1.01-74.01%
2021ยฃ3.88-66.58%
2020ยฃ11.6198.24%
2019ยฃ5.8617.01%
2018ยฃ5.0037.78%
2017ยฃ3.63-27.62%
2016ยฃ5.0235.33%
2015ยฃ3.71-2.82%
2014ยฃ3.82-27.66%
2013ยฃ5.27-27.49%
2012ยฃ7.28-12.67%
2011ยฃ8.3388.08%
2010ยฃ4.43-11.06%
2009ยฃ4.98-390.15%
2008-ยฃ1.72-127.78%
2007ยฃ6.18347.11%
2006ยฃ1.384.38%
2005ยฃ1.327.4%
2004ยฃ1.2343.03%
2003ยฃ0.8625.09%
2002ยฃ0.6952.67%
2001ยฃ0.4569.76%
2000ยฃ0.27